MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer

$ 8.50

4.8
(611)
In stock
Description

Macrophages confer resistance to BET inhibition in triple-negative

Opnurasib (JDQ-443) is an Orally Active KRAS G12C Inhibitor

Rociletinib (CO-1686) is an Orally Active EGFR-Mutant Inhibitor

Triple-Negative Breast Cancer - Network of Cancer Research

SC-43 is a Potent and Orally Active SHP-1 Agonist and STAT3

Elesclomol (STA-4783) is an Oxidative Stress Inducer and Induces Apoptosis

RETRACTED ARTICLE: A new synthetic derivative of cryptotanshinone

Purinostat mesylate is a Selective HDAC Inhibitor With anti-Leukemia Effects

triple-negative breast cancer MedChemExpress (MCE) Life Science

MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer

Navitoclax (ABT-263) is an Orally Active Bcl-2 Inhibitor for

DC-5163, a GAPDH Inhibitor, Inhibits Glycolysis Pathway and Induces Apoptosis

triple-negative breast cancer MedChemExpress (MCE) Life Science

Arnicolide D Inhibits Triple Negative Breast Cancer Cell

Established synthetic method of psammaplin A analog and